Bayesian Capital Management’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,900
Closed -$2.07M 359
2025
Q3
$2.07M Sell
13,900
-3,800
-21% -$557K 0.42% 68
2025
Q2
$2.57M Buy
17,700
+10,300
+139% +$1.49M 0.41% 62
2025
Q1
$936K Sell
7,400
-13,700
-65% -$1.73M 0.15% 179
2024
Q4
$2.19M Buy
21,100
+15,300
+264% +$1.46M 0.27% 107
2024
Q3
$495K Sell
5,800
-7,800
-57% -$603K 0.06% 379
2024
Q2
$959K Buy
+13,600
New +$907K 0.11% 242
2023
Q4
Sell
-16,107
Closed -$725K 913
2023
Q3
$725K Buy
16,107
+5,800
+56% +$236K 0.08% 277
2023
Q2
$384K Buy
+10,307
New +$412K 0.04% 467
2022
Q2
Sell
-12,332
Closed -$448K 950
2022
Q1
$448K Buy
+12,332
New +$409K 0.07% 402
2020
Q4
Sell
-9,950
Closed -$262K 577
2020
Q3
$262K Buy
+9,950
New +$385K 0.06% 376
2019
Q1
Sell
-12,260
Closed -$304K 676
2018
Q4
$304K Buy
+12,260
New +$262K 0.06% 411

Other funds holding LRN

Bayesian Capital Management's LRN Position: Q4 2025 in Review

Bayesian Capital Management sold out of Stride (LRN) in Q4 2025, closing a stake of 13,900 shares — an estimated $2.07M sold.

Bayesian Capital Management first reported a position in LRN in Q4 2018 and held it in 11 quarters. The position peaked at $2.57M in Q2 2025. 396 funds tracked by Wall St. Rank hold LRN as of Q4 2025.

  • Bayesian Capital Management reported no remaining Stride position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 13,900 Stride shares in Q4 2025, an estimated $2.07M.
  • Bayesian Capital Management first reported a position in Stride in Q4 2018 and held it in 11 quarters.
  • Bayesian Capital Management's Stride position peaked at $2.57M in Q2 2025.
  • 396 funds tracked by Wall St. Rank held Stride as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.